NASAFYTOL® supplementation in adults hospitalized with COVID-19 infection: results from an exploratory open-label randomized controlled trial
- DOI
- 10.3389/fnut.2023.1137407
- Published
- 2023-06-22
- Container
- Frontiers in Nutrition
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fnut.2023.1137407,
title = {NASAFYTOL® supplementation in adults hospitalized with COVID-19 infection: results from an exploratory open-label randomized controlled trial},
author = {Jean Gérain and Melanie Uebelhoer and Bérénice Costes and Julie Herman and Sandra Pietri and Anne-Françoise Donneau and Justine Monseur and Yves Henrotin},
year = {2023},
journal = {Frontiers in Nutrition},
doi = {10.3389/fnut.2023.1137407},
url = {https://doi.org/10.3389/fnut.2023.1137407}
}RIS
TY - JOUR TI - NASAFYTOL® supplementation in adults hospitalized with COVID-19 infection: results from an exploratory open-label randomized controlled trial AU - Jean Gérain AU - Melanie Uebelhoer AU - Bérénice Costes AU - Julie Herman AU - Sandra Pietri AU - Anne-Françoise Donneau AU - Justine Monseur AU - Yves Henrotin PY - 2023 JO - Frontiers in Nutrition DO - 10.3389/fnut.2023.1137407 UR - https://doi.org/10.3389/fnut.2023.1137407 ER -
APA
Gérain, J., Uebelhoer, M., Costes, B., Herman, J., Pietri, S., Donneau, A., Monseur, J., & Henrotin, Y. (2023). NASAFYTOL® supplementation in adults hospitalized with COVID-19 infection: results from an exploratory open-label randomized controlled trial. Frontiers in Nutrition. https://doi.org/10.3389/fnut.2023.1137407
Source records
- crossref · retrieved 2026-09-25T16:58:08.015Z